- Home
- MCW vs AKRO Comparison
MCW vs AKRO Comparison
Compare MCW & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCW
- AKRO
- Stock Information
- Founded
- MCW 1996
- AKRO 2017
- Country
- MCW United States
- AKRO United States
- Employees
- MCW N/A
- AKRO N/A
- Industry
- MCW
- AKRO Biotechnology: Pharmaceutical Preparations
- Sector
- MCW
- AKRO Health Care
- Exchange
- MCW Nasdaq
- AKRO Nasdaq
- Market Cap
- MCW 2.5B
- AKRO 2.0B
- IPO Year
- MCW 2021
- AKRO 2019
- Fundamental
- Price
- MCW $7.12
- AKRO $25.14
- Analyst Decision
- MCW Buy
- AKRO Strong Buy
- Analyst Count
- MCW 6
- AKRO 8
- Target Price
- MCW $9.08
- AKRO $46.83
- AVG Volume (30 Days)
- MCW 862.1K
- AKRO 842.7K
- Earning Date
- MCW 02-19-2025
- AKRO 02-27-2025
- Dividend Yield
- MCW N/A
- AKRO N/A
- EPS Growth
- MCW N/A
- AKRO N/A
- EPS
- MCW 0.22
- AKRO N/A
- Revenue
- MCW $973,695,000.00
- AKRO N/A
- Revenue This Year
- MCW $8.08
- AKRO N/A
- Revenue Next Year
- MCW $8.28
- AKRO N/A
- P/E Ratio
- MCW $32.35
- AKRO N/A
- Revenue Growth
- MCW 6.85
- AKRO N/A
- 52 Week Low
- MCW $5.84
- AKRO $15.32
- 52 Week High
- MCW $9.45
- AKRO $37.00
- Technical
- Relative Strength Index (RSI)
- MCW 44.16
- AKRO 41.89
- Support Level
- MCW $6.96
- AKRO $21.34
- Resistance Level
- MCW $7.29
- AKRO $28.94
- Average True Range (ATR)
- MCW 0.21
- AKRO 1.38
- MACD
- MCW 0.01
- AKRO -0.27
- Stochastic Oscillator
- MCW 40.28
- AKRO 49.67
About MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue in two main streams. It offers an Unlimited Wash Club (UWC) program to its customers. The UWC program entitles the customer to unlimited washes for a monthly fee, cancellable at any time. Second, revenue from the car wash and quick lube services.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.